Ecovyst Inc. (ECVT): what the price assumes

In the published model solve dated 2026-Q2, anchored at $10.41, Ecovyst Inc. (ECVT) is priced for +7.1% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/ECVT

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 9.1% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.4%); the inversion above states its own rate.

Per-Model Detail (n=12)

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• Ecovyst runs a waste-processing business dressed as a chemicals company: refiners send it their spent sulfuric acid, it regenerates the acid and sends it back, and the filing confirms the raw material arrives free because Spent sulfuric acid for our regeneration services product group is supplied by customers as part of their contracts.
• Revenue growth flatters the picture right now, because sales rose $71.9 million to $215.0 million in the March 2026 quarter largely on passing higher sulfur costs through to customers, which the 10-Q says produces no net impact to gross profit.
• The customer base is the concentrated risk, and it is getting more so: the 10-K warns that Refineries, which represent a sizable subset of our customer base, have undergone significant consolidation and additional consolidation is possible in the future.

Bull Case

The headline numbers and the business have been telling different stories for a year, and the gap is worth unpicking before anything else. Sales in the March 2026 quarter rose $71.9 million to $215.0 million, which looks like an extraordinary growth rate for a specialty chemicals company. Most of it was sulfur. The 10-Q is explicit that the cost of sulfur is generally passed through to customers at the same rate as incurred, resulting in no net impact to gross profit, and that roughly 33 million dollars of the increase was exactly that. So the top line inflated while the economics underneath did something quieter and more useful.

What they did was turn positive. Net income from continuing operations was $5.7 million in the March 2026 quarter against a net loss from continuing operations of $8.1 million a year earlier. That swing came from the operating business, not from the disposal that dominates the reported annual figures, and it happened in the seasonally weaker part of the year: the filing notes that the regeneration services business sees higher gasoline demand in summer, which pushes sales into the second and third quarters.

The underlying franchise is unusual in a way that does not show up in a multiple. Refiners running alkylation units produce spent sulfuric acid as a by-product, and Ecovyst takes it, regenerates it and returns it. The customer supplies the feedstock; the company supplies a plant next door and a permit. That structure is why the contract terms look the way they do, with most contracts carrying take-or-pay volume protection and quarterly price adjustments indexed to commodity inputs, labour and a chemical plant construction cost index. Volume risk and input risk both sit largely with the customer. The company describes the physical position plainly: We believe that our efficient network of strategically located, owned manufacturing facilities provides us with a strong competitive advantage in serving our customers, and that it would be costly for our competitors to replicate our network.

Management has also simplified aggressively and paid itself back for it. Effective December 31, 2025 the company completed the sale of our Advanced Materials & Catalysts segment, which includes our investment in affiliated companies, Zeolyst International and Zeolyst C.V. (collectively, the "Zeolyst Joint Venture") to Technip Energies N.V. for a purchase price of $556.0 million, leaving what the 10-K describes as one reporting unit and one reporting segment, Ecoservices. In the March 2026 quarter alone it bought back 3,226,461 shares for a total cost of $35.7 million, with $146.5 million still authorised, and the share count has been falling at roughly 5.3% a year over the four years to March 2026. Selling half the company and buying back the stock with the proceeds is a coherent view about where value sits.

Regulation is the quiet tailwind under all of it. The 10-K ties demand for regenerated acid to the octane requirements of US gasoline, including the full implementation of Tier 3 gasoline sulfur standards enacted in 2020, which requires blending additional low sulfur, high octane material. Alkylate is how refiners get there, and alkylation needs sulfuric acid.

Bear Case

The moat depends on the customers staying numerous, and the filing says they are not. Refineries, which represent a sizable subset of our customer base, have undergone significant consolidation and additional consolidation is possible in the future. The 10-K then completes the thought: such consolidation could increase reliance on a small number of customers and increase their leverage, putting downward pressure on prices. A business whose defence is a plant sited next to a refinery is only as defensible as the refinery's willingness to keep buying, and each merger on the customer side removes a bidder from the table when the contract comes up.

The company has also just made itself smaller and more concentrated. The Advanced Materials & Catalysts business, and with it the Zeolyst joint venture, went to Technip Energies effective December 31, 2025, and what remains is a single reporting segment. That is a cleaner story, but it is also a narrower one: one end market, one chemistry, one set of counterparties, and a demand profile tied to gasoline volumes that the energy transition is not obviously kind to over a five-year horizon.

Meanwhile the price is not asking for a quiet life. At about 17 times company-wide operating profit, it embeds operating growth of roughly 14.5% a year sustained for five years. Only about half of comparable fast growers historically held that pace over such a span, and this particular company has just sold the part of itself that carried the higher-growth chemistry. The near-term rate is inside what the business has recently delivered; the difficulty is the persistence, from a smaller base, in a market where the input cost is passed through and therefore cannot be a source of expanding margin.

The reported margin picture also flatters more slowly than the revenue does. Because sulfur costs run through both sides of the income statement, a period of high sulfur prices inflates sales and mechanically compresses the operating margin without anything going wrong, and a period of low sulfur prices does the reverse. Anyone reading the margin as a measure of operating performance is reading a commodity index with extra steps. Trailing operating margin is running near 9.9%, against operating margins of 15.7% at CBT and 13.4% at ESI, and part of that gap is optical rather than real, which cuts both ways: it also means the reported improvement anyone expects from cost deflation would be optical too.

Underneath, the balance sheet leaves less room than the tidy divestiture suggests. Net borrowings stand at roughly 230.2 million dollars, and operating profit covers the interest bill only about 2.5 times over, with interest expense running at 34.2 million dollars in 2025. That is manageable while the plants run and the take-or-pay contracts hold. It is a good deal less manageable through a heavy turnaround season or a refinery closure in the wrong region, and the asset-value and earnings-power methods both land well below today's price, with the price sitting at roughly 2.7 and 3.0 times where those two families reach.

Valuation

Today's $12.47 works out to about 17 times company-wide operating profit, and running that backwards gives a specific demand: operating profit compounding at roughly 14.5% a year for five years. That rate is inside what the business has recently delivered, so the question is not whether it is achievable in a good year. It is whether it holds for five of them. On the historical record, only about 51% of comparable fast growers sustained that pace over a similar span, and this multiple sits in the lower half of its peer range rather than at the top, which is why the assumption reads as demanding but not extreme.

The methods split cleanly into two camps, and the split is informative. Peer multiples and the growth-based cash-flow methods land at or above the price. The asset-value and earnings-power methods land well below it, with the price at roughly 2.7 times the asset family and about 3.0 times the earnings-power family. That gap is not a technical curiosity. Book equity is only 5.15 dollars a share, because a business built on regeneration plants and long-lived permits carries a modest balance sheet relative to the cash it throws off, and the earnings-power method values a five-year average of operating profit at no growth. So the price is paying for the contract structure and the growth, not for the assets or for a static earnings stream.

The operating numbers behind that need reading carefully. Sales rose $71.9 million to $215.0 million in the March 2026 quarter, but the 10-Q attributes most of the increase to passing higher sulfur costs through to customers, which it says produces no net impact to gross profit. Trailing operating margin near 9.9% is therefore partly a function of where sulfur trades rather than of how well the plants run. Net income from continuing operations of $5.7 million in the quarter, against a loss from continuing operations of $8.1 million a year earlier, is the cleaner signal, since it strips out the December divestiture that dominates the annual figures.

Capital allocation and the balance sheet close the picture from opposite directions. Net borrowings of roughly 230.2 million dollars against operating profit that covers the interest bill about 2.5 times over is a real constraint on how bad a season the company can absorb. Against that, 3,226,461 shares were bought back for $35.7 million in the March quarter with $146.5 million of authorisation left, funded by a divestiture that brought in a purchase price of $556.0 million. The company is shrinking its share count faster than most of its cohort, which means the growth the price requires has fewer claims on it than it did two years ago.

Catalysts

Second-quarter results are scheduled for August 5, 2026, and they land in the seasonally strong half of the year, since the filing notes that regeneration demand rises with summer gasoline consumption and pushes sales into the second and third quarters.

The bigger item is already done. On May 1, 2026 the company agreed to acquire Calabrian's sulfur dioxide and sulfur derivatives business for $190 million, and it completed that acquisition on June 30, 2026. It also completed a term loan amendment and increase on May 14, 2026, which is how the purchase was funded. None of that appears in the trailing figures in this report, so the second-quarter statements are the first place the added revenue, the added interest cost and the added leverage will show up together.

Guidance is the third thing in play. The company revised its 2026 outlook when it released first-quarter results on May 5, 2026, before the Calabrian deal closed. Whether the August update folds the acquisition into the full-year framing, and on what terms, is the most direct read available on how management expects the enlarged sulfur franchise to earn.

Peer Cohorts (Per Segment, With Filing Citations)

Ecoservices (consolidated) (reported)

• NGVT (INGEVITY CORPORATION)
• FY2025 10-K: …our reportable segment results. Refer to Note 5 for more information. (6) For the year ended December 31, 2025, charge relates to the Performance Chemicals reportable segment. Refer to Note 7 and Note 8 for more information. 40 (7) Charges represent legal and other professional service fees as well as incremental…
• FY2025 10-K: Exchange Commission on February 19, 2025). 10. 80 + Service-Based Interim CEO Restricted Stock Unit Award Terms and Conditions (incorporated by reference to Exhibit 10.81 to the Company's Annual Report on Form 10-K, as filed with the U.S. Securities and Exchange Commission on February 19, 2025). 10.8 1 + Offer Letter…
• CBT (Cabot Corporation)
• FY2025 10-K: …activities, interest and dividend income, the profit or loss related to the corporate adjustment for unearned revenue, and unrealized holding gains (losses) for investments. This does not include items of income or expense that are separately treated as Certain items. (4) Equity in earnings of affiliated companies,…
• FY2025 10-K: …costs that are reasonably possible to be in excess of amounts already recorded would be immaterial to the Company's consolidated financial statements. Charges for environmental expenses were $ 1 million in each of fiscal 2025, 2024 and 2023, and are included in Cost of sal es in the Consolidated Statements of…
• ESI (Element Solutions Inc)
• FY2025 10-K: …when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current laws and existing technologies. Costs related to environmental contamination treatment and cleanup are charged to expense. The accruals are adjusted periodically as assessment and…
• FY2025 10-K: …and sells specialty chemicals and material process technologies that enhance surfaces or improve industrial processes in diverse industrial sectors from automotive trim to transcontinental infrastructure to high-design faucets. Its products include chemical systems that protect and decorate metal and plastic surfaces…
• IOSP (INNOSPEC INC.)
• FY2025 10-K: …demand from certain customers, together with lower provisions for performance-related remuneration accruals. Other Income Statement Captions Corporate costs: the year over year increase of $2.6 million was due to the prior year including the recovery of $8.4 million of historical pension costs, increased provisions…
• FY2025 10-K: …with developing customer needs. In addition, the business has developed further formulations in emollients, silicones and surfactants for the personal care, home care, agrochemical, construction, mining and other industrial markets. Fuel Specialties has continued to innovate, focused on bringing new technologies to…
• CSW (CSW INDUSTRIALS, INC.)
• FY2025 10-K: …of operations and results for each of our segments. The operations of PF WaterWorks have been included in our consolidated results of operations and in the operating results of our Contractor Solutions segment since the November 4, 2024 date of acquisition. The operations of PSP Products ("PSP") have been included in…
• FY2025 10-K: …our customers prefer, and we remain focused on the products and subcategories that are growing faster than the overall industry. We believe we have the strategy and the team to deliver strong performance in fiscal 2026. We expect to maintain a strong balance sheet in fiscal year 2026, which provides us with access to…
• AVNT (AVIENT CORPORATION)
• FY2025 10-K: NT CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Note 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business We are an innovator of materials solutions to help our customers succeed, while enabling a sustainable world. Our products include specialty engineered…
• FY2025 10-K: Corporation, the subsidiaries of Avient Corporation party thereto, the existing lenders under the Term Loan Agreement, Citibank, N.A, as administrative agent, and Truist Bank, as the Amendment No. 10 Additional Term Lender (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed…
• SXT (Sensient Technologies Corp)
• FY2025 10-K: …The Company uses advanced technologies at facilities around the world to develop specialty food and beverage systems; personal care, essential oils, pharmaceutical, and nutraceutical systems; specialty colors; and other specialty and fine chemicals. The Company's three reportable segments are the Flavors & Extracts…
• FY2025 10-K: …and Board of Directors of Sensient Technologies Corporation Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Sensient Technologies Corporation (the Company) as of December 31, 2025 and 2024, the related consolidated statements of earnings, comprehensive income,…
• MTX (MINERALS TECHNOLOGIES INC.)
• FY2025 10-K: …to arrive at operating profit do not include several items, such as net interest or income tax expense. Depreciation expense related to corporate assets is allocated to the business segments and is included in their income from operations. However, such corporate depreciable assets are not included in the segment…
• FY2025 10-K: …products. Continue to develop innovative applications for our bleaching earth products for edible oil and renewable fuel industries. Develop natural and mineral-based solutions for personal care applications. Increase our presence and market share globally for retinol delivery technology for personal care…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.